In a high-stakes appeal to the halls of Congress, the metastatic breast cancer (MBC) advocacy organization METAvivor...
The global industrial landscape is undergoing a silent, tectonic shift. For over a century, the backbone of...
New York, NY / Cambridge, MA – June 22, 2024 – In a significant scientific breakthrough that...
Introduction: The Philosophy of the Second Chance For many, the phrase "every day is like Christmas" is...
In the modern clinical trial landscape, the sheer volume of data has transcended human capacity. Between 2020...
For decades, the primary metric of success in the fight against breast cancer has been survival. As...
For decades, Botulinum toxin type A—widely recognized by its trade name, Botox—has been the gold standard in...
In a development that has sent ripples of concern through the global healthcare infrastructure, Boston Scientific—a titan...
By Jessica Baladad, Breast Cancer Survivor and Patient Advocate The pronouncement of "no evidence of disease" is...
Main Facts: A New Chapter in Precision Cardiology The Broad Institute of MIT and Harvard, a global...
